suppressed after only one month's treatment.'2 We, however, found that the inhibition of bone resorptionis temporary and that control of the disease needs repeated courses of treatment.
The precise mechanism causing the mineralisation defect is not known but was unrelated to changes in 1,25(OH)2 vitamin D in this study. Possible side effects of sodium etidronate include interference with alkaline phosphatase activity, reduced synthesis of proteoglycans, and a toxic effect on bone cells. 14 In conclusion, sodium etidronate 20 mg/kg/day results in a biochemical improvement in Paget's disease when given for as short a period as two to four weeks, but it produces a mineralisation defect and the effect on bone resorption is not permanent. Although the defect in mineralisation spontaneously corrects when treatment is stopped we doubt whether any manipulation ofthe dose or duration of tieatment can dissociate the drug's beneficial effects on resorption from its adverse effects on mineralisation. It is not, therefore, ideal for long term management of patients with Paget's disease.
Introduction
In 1965 Wilson showed that plasma and urinary thiocyanate concentrations were lower in a group of smokers with Leber's hereditary optic neuropathy than in a control group without this neuropathy.' This and the finding of raised plasma cyanocobalamin concentrations in these patients' led to the hypothesis that there is an inborn error in cyanide detoxication in patients with Leber's hereditary optic neuropathy." Another hypothesis is that Leber's hereditary optic neuropathy is a hereditary vascular neuroretinopathy. 4 The main detoxication route for cyanide is the enzymic transfer of sulphur from thiosulphate (or mercaptopyruvate) to cyanide to form thiocyanate. Wilson found no difference in the activity of thiosulphate sulphurtransferase (rhodanese; EC 2.8.1.1) in liver samples taken at necropsy of two patients who had had Leber's hereditary optic neuropathy compared with samples from controls. ' In 1981, however, Cagianut et al reported reduced activity of liver rhodanese in two patients with Leber's hereditary optic neuropathy compared with living and dead controls. 5 Rhodanese is an intramitochondrial enzyme and therefore may be found in most tissues; it occurs in large quantities in the liver and kidneys. For ethical and practical purposes rectal mucosa was chosen as the -source of specimens for our enzyme assays. We compared the activity of rectal mucosa rhodanese in subjects with Leber's hereditary optic neuropathy with that in control subjects. In addition, rhodanese activity was measured in liver and rectal mucosa obtained at necropsy from controls.
Patients and methods
Ten white men with Leber's hereditary optic neuropathy from nine different families living in southern England were studied. All had optic atrophy that was inherited matroclinically and fulfilled the criteria of the diagnosis of Leber's hereditary optic neuropathy described by Lundsgaard6 -namely, a predominantly male affection with acute or subacute bilateral visual loss with central scotomas. At least one subject on the maternal side of each pedigree had been similarly affected. Control specimens were obtained from 12 white patients (seven men, five women) undergoing investigations for various bowel disorders such as carcinoma, colitis, and idiopathic diarrhoea ("diseased" controls) and from 20 white patients (17 men, three women) undergoing routine colonoscopy for colonic polyps ("healthy" controls). Three doctor volunteers also acted as "healthy" controls. Rectal mucosa was obtained by the usual technique ofsigmoidoscopy orcolonoscopy with biopsy forceps. Postmortem rectal mucosa and liver samples were taken from cadavers with non-neuro-ophthalmic disease at St Thomas's Hospital, London.
Specimens were stored at -20°C for up to one month until assayed. Known weights of tissue were homogenised in ice cold glycine (0-1 mol/1) using a microtissue grinder and then centrifuged at 3000 rpm for 30 minutes at 4°C. A 5-30 mg sample of wet tissue was used to make a final homogenate volume of 400-1000 W1. After centrifugation 50.pd of the clear supernatant was used to measure rhodanese activity by the method of Sorbo.7 Volumes of reagents were scaled down by a factor of 10 to provide a micromethod, thereby using less of the potentially hazardous cyanide solution and also accommodating the smaller sample volume. Samples were incubated at 370C for 20 minutes. A blank tube was set up for each test sample in which all reagents were present. These were incubated for the same time, but the tissue extract was added after the addition of the formaldehyde, which was used to stop the enzyme reaction. A further 50 pl of the supernatant was used to measure protein concentration by the Ponceau S-trichloracetic acid micromethod.8 Enzyme activity was expressed as pmol thiocyanate/g protein/min.
A two tailed Mann-Whitney test was used to compare subjects with Leber's hereditary optic neuropathy with healthy and diseased controls.
Results
Mean age of the subjects with Leber's hereditary optic neuropathy was 39 (range 22-58) years. The duration ofoptic atrophy varied from six months to 24 years. We considered this group to be representative of patients with Leber's hereditary optic neuropathy. Mean ages of the healthy and diseased controls were 61 (30-89) years and 54 (33-79) years, respectively. Thostcnuropate y suphutransferas (rodanseactivyl i subjectser with Leber'st between sex,! age, weight of biopsy specimen, duration of storage, and enzyme activity. The intra-assay precision varied by less than 5%. Supernatant from the mucosal extract of a subject with Leber's hereditary optic neuropathy was added to that of a control sample but had no effect on the enzyme-activity. The mean (SEM) activity ofrhodanese in rectal mucosa and liver obtained at necropsy-was 198 (41-9) sumol thiocyanate/g protein/min (n= II) and 4712 (205 6) pimol thiocyanate/g protein/mni (n=8), respectively.
Discussion
The finding of reduced rhodanese activity in the rectal mucosa of subjects with Leber's hereditary optic neuropathy substantiates the report of Canut et al of such a reduction in the livers of two patients with this neuropathy.5 This supports earlier evidence suggesting an inborn error ofcyanide detoxication in'this condition.
The sixfold reduction in the activity ofrhodanese in rectal mucosa found in this study is also similar in magnitude to the reduction in hepatic tissue reported by Cagianut et al. The recent report of normal rhodanese activity in the anterior tibial muscle of subjects with Leber's hereditary optic neuropathy9 does not detract from our findings as there may be tissue specific isoenzymes of rhodanese. Defective enzyme activity may be expressed only in the rectal mucosa, hepatic tissue, and optic nerve. It is therefore important to measure the activity of rhodanese in optic nerves as well as performing family studies ofrhodanese activity.
In a matroclinally inherited disease such as Leber's hereditary optic neuropathy all the offspring of a carrer woman are at risk of developing the disease. When advice is given the hazards of smoking cigarettes and ingesting dietary cyanogenetic substances, such as almonds, beans, peas, and cassava, need to be explained to patients and their relatives. 
